Suggest guests or get in contact

Episode 17 — GLP-1 in Type 1 Diabetes: Beyond Weight Loss, Towards Metabolic Therapy

 Go to the Podcast page for all the notes, insights, and further reading & listening.

Subscribe to The Glucose Never Lies® and receive the Summary PDF with all the key take-home messages and practical implementation strategies. 

Support The Glucose Never Lies® Podcast
☕ Buy Me a Coffee
💙 Donate

Guest: Professor Viral Shah, MD

• Professor of Medicine & Director of Diabetes Clinical Research, Center for Diabetes and Metabolic Diseases, IU School of Medicine
• Author of multiple clinical trials and consensus guidelines on GLP-1 and incretin therapies in type 1 diabetes

In this episode, John Pemberton speaks with Professor Viral Shah, a leading researcher in incretin therapies, about:

• The unique challenges of type 1 diabetes (insulin resistance, glucagon, weight gain).
• The evidence for GLP-1s in T1D: up to 30% insulin reduction, weight loss, and improved time in range.
• Practical guidance for people with type 1 and healthcare professionals: insulin titration, MDI vs pump vs AID, nutrition, and risk–benefit.

Subscribe to The Glucose Never Lies® and receive the Summary PDF with all the key take-home messages and practical implementation strategies. 

Go to the Podcast page for all the notes, insights, and further reading & listening.

Related GNL Resources

• Overcoming Insulin Resistance in T1D
• Eight Causes of Insulin Resistance
• Seven Ways to Combat Insulin Resistance
• Automated Insulin Delivery Series
• CGM Series
• GNL Podcast Episode 14 Overcoming Insulin Resistance